Russo LM, Nobles C, Ertel KA, et al
Molecular Psychiatry 18, 961962.CrossRefGoogle ScholarPubMed Hall, MH, Chen, CY, Cohen, BM, Spencer, KM, Levy, DL, ngr, D and Smoller, JW (2015) Genomewide association analyses of electrophysiological endophenotypes for schizophrenia and psychotic bipolar disorders: a preliminary report
, The most recent published research (January 2025), a large nationwide case-time-control study using data in France, found no evidence that GLP-1 use increased short-term risk of suicide or suicide attempt in patients with obesity or history of psychiatric disorders
Ozempic Vision Loss Injuries and Lawsuits Ozempic & Vision Loss (NAION) Ozempic NAION concerns are growing as studies link semaglutide drugs to sudden, permanent vision loss
1 prefilled FlexTouch pen containing 2.4 mg semaglutide in 0.5 mL Designed for one-time use only Administered using NovoFine or compatible needles (not included) Pen is color-coded and labeled to avoid dosing errors Side effects are common but typically manageable and dose-dependent , often occurring during the titration phase